Register for our free email digests:
Latest From PLUS Diagnostics
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January through February 2014.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Urine-based Testing
Laboratory Testing Services
- Anatomical Pathology
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- PLUS Diagnostics
- Senior Management
Dave Pauluzzi, CEO
Tim Kennedy, EVP, CFO
Adnan Savera, MD, CMO
Edwin Hendrick, EVP, Sales & Mktg.
Josephine Pulcinello, SVP, Bus. Dev. & Strategy
- Contact Info
Phone: (732) 901-7575
825 Rahway Ave.
Union, NJ 07083
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.